This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Twycross R, Zenz M (1983) Use of oral morphine in incurable pain. Anaesthesist 32:279–283
Lewington VJ (1996) Cancer therapy using bone-seeking isotopes. Phys Med Biol 41:2027–2042
Tong EC, Finkelstein P (1973) The treatment of prostatic bone metastases with parathormone and radioactive phosphorus. J Urol 109:71–75
Eisenhut M, Berberich R, Kimmig B, Oberhausen E (1986) Iodine-131-labeled diphosphonates for palliative treatment of bone metastases: II. Preliminary clinical results with iodine-131 BDP3. J Nucl Med 27:1255–1261
Eisenhut M, Fritz P, Kimmig B, Wingen F, Krempien B (1986) Iodine-131-labeled diphosphonates for the palliative treatment of bone metastases-III. Considerations of interaction, binding and absorbed dose. Int J Rad Appl Instrum 37:741–747
Kutzner J, Dahnert W, Schreyer T, Grimm W, Brod KH, Becker M (1981) [Treatment of pains from bone metastases with 90Y (author’s transl)]. Nuklearmedizin 20:229–235
Atkins HL, Mausner LF, Srivastava SC, Meinken GE, Cabahug CJ, D’Alessandro T (1995) Tin-117m(4+)-DTPA for palliation of pain from osseous metastases: a pilot study. J Nucl Med 36:725–729
Maxon HR, 3rd, Thomas SR, Hertzberg VS, Schroder LE, Englaro EE, Samaratunga R, Scher HI, Moulton JS, Deutsch EA, Deutsch KF et al (1992) Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases. Semin Nucl Med 22:33–40
Porter AT, McEwan AJ, Powe JE, Reid R, McGowan DG, Lukka H, Sathyanarayana JR, Yakemchuk VN, Thomas GM, Erlich LE et al (1993) Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 25:805–813
Goeckeler WF, Troutner DE, Volkert WA, Edwards B, Simon J, Wilson (1986) 153Sm radiotherapeutic bone agents. Int J Rad Appl Instrum 13:479–482
Goeckeler WF, Edwards B, Volkert WA, Holmes RA, Simon J, Wilson D (1987) Skeletal localization of samarium-153 chelates: potential therapeutic bone agents. J Nucl Med 28:495–504
Eary JF, Collins C, Stabin M, Vernon C, Petersdorf S, Baker M, Hartnett S, Ferency S, Addison SJ, Appelbaum F et al (1993) Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med 34:1031–1036
Serafini AN (1994) Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease. Int J Radiat Oncol Biol Phys 30:1187–1194
Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA (1998) Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 16:1574–1581
Resche I, Chatal JF, Pecking A, Ell P, Duchesne G, Rubens R, Fogelman I, Houston S, Fauser A, Fischer M, Wilkins D (1997) A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 33:1583–91
Klingelschmitt S, Boulahdour H, Blagosklonov O, Rudenko B, Aubry R, Bidet A-C, Bosset J-F, Cardot J-C (2002) Traitement des métastases osseuses douloureuses par Quadramet: Expérience rétrospective chez 77 patients sur 2 ans. Médecine nucléaire 26(9):461–469
Boulahdour H, Benmelha Z, Aubry R, Klingelschmitt S, Rudenko B, Loboguerrero A, Cardot J-C (2001) Traitement antalgique des métastases osseuses: apport de la radiothérapie métabolique. Séance “Radiologie thérapeutique non invasive”, JFR, Paris, 20–24 octobre. Communication orale
Lovera C, Massardo T, Galleguillos MC, Gonzalez P, Comparini B, Yanez M, Fodor M, Gil MC, Araya G, Tomicic M (1998) [Analgesic response and secondary effects in patients with osteoblastic metastasis, treated with Samarium 153 ethylenediaminotetramethylenephosphate]. Rev Med Chil 126:963–971
Ahonen A, Joensuu H, Hiltunen J, Hannelin M, Heikkila J, Jakobsson M, Jurvelin J, Kairemo K, Kumpulainen E, Kulmala J et al (1994) Samarium-153-EDTMP in bone metastases. J Nucl Biol Med 38:123–127
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Boulahdour, H., Klingelschmitt, S. (2007). Treating Painful Osseous Metastases by Internal Radiation Therapy. In: Kastler, B., Barral, FG., Fergane, B., Pereira, P. (eds) Interventional Radiology in Pain Treatment. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-47199-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-540-47199-8_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-24810-1
Online ISBN: 978-3-540-47199-8
eBook Packages: MedicineMedicine (R0)